These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 30746199)

  • 1. A specific subtype of chronic obstructive pulmonary disease classified by forced vital capacity.
    Chen C; He Y; Chen Q; Zhang D; Wang Y; Tang Y; Fang Y; Zhong N; Jian W; Zheng J
    J Thorac Dis; 2018 Dec; 10(12):6547-6556. PubMed ID: 30746199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of heart failure on the classification of COPD severity.
    Güder G; Rutten FH; Brenner S; Angermann CE; Berliner D; Ertl G; Jany B; Lammers JW; Hoes AW; Störk S
    J Card Fail; 2012 Aug; 18(8):637-44. PubMed ID: 22858080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the Bronchodilator Test Defined by the Forced Vital Capacity in Chronic Obstructive Pulmonary Disease Phenotyping.
    Zhang X; Wu Z; Liu Y; Jiang S
    Int J Chron Obstruct Pulmon Dis; 2020; 15():1199-1206. PubMed ID: 32547006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bronchodilator Responsiveness Defined by the 2005 and 2021 ERS/ATS Criteria in Patients with Asthma as Well as Chronic Obstructive Pulmonary Disease.
    Li Y; Lin J; Wang Z; Wang Z; Tan L; Liu S; Huang J; Gao Y; Zheng J
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2623-2633. PubMed ID: 36274994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the clinical phenotype of symptomatic chronic airways disease by hierarchical cluster analysis and two-step cluster analyses].
    Ning P; Guo YF; Sun TY; Zhang HS; Chai D; Li XM
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):679-83. PubMed ID: 27586974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.
    Fortis S; Comellas A; Make BJ; Hersh CP; Bodduluri S; Georgopoulos D; Kim V; Criner GJ; Dransfield MT; Bhatt SP;
    Ann Am Thorac Soc; 2019 Jul; 16(7):826-835. PubMed ID: 30908927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Values of Body Mass Index and Chest CT Features in the Assessment of Chronic Obstructive Pulmonary Disease].
    Li L; Liu Y; Li J; Gao JM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Feb; 42(1):55-61. PubMed ID: 32131940
    [No Abstract]   [Full Text] [Related]  

  • 8. Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease.
    Pisi R; Aiello M; Zanini A; Tzani P; Paleari D; Marangio E; Spanevello A; Nicolini G; Chetta A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1191-7. PubMed ID: 26150710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of FEV
    Jang JG; Kim Y; Shin SH; Min KH; Jung KS; Kim YI; Park S; Na JO; Lee H; Yoo KH
    Respir Med; 2024 Aug; 234():107780. PubMed ID: 39216610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of bronchodilator responsiveness in asthma and chronic obstructive pulmonary disease.
    Chhabra SK; Bhatnagar S
    Indian J Chest Dis Allied Sci; 2002; 44(2):91-7. PubMed ID: 12026258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of lung volume response with airflow response to bronchodilator in patients with chronic obstructive pulmonary disease].
    Zhang FQ; Zheng JP; Wang JH; Lu WB; Wu RX; Li XS; Xian QZ; Gao Y; Jiang M
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Feb; 33(2):109-13. PubMed ID: 20367950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the difference between FEV1 change in percentage predicted value and change over baseline in the assessment of bronchodilator responsiveness in patients with COPD?
    Jian W; Zheng J; Hu Y; Li Y; Gao Y; An J
    J Thorac Dis; 2013 Aug; 5(4):393-9. PubMed ID: 23991293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malnutrition, Airflow Limitation and Severe Emphysema are Risks for Exacerbation of Chronic Obstructive Pulmonary Disease in Japanese Subjects: A Retrospective Single-Center Study.
    Yamaya M; Usami O; Nakayama S; Tode N; Yamada A; Ito S; Omata F; Momma H; Funakubo M; Ichinose M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():857-868. PubMed ID: 32368031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The importance of lung volumes in the investigation of heavy smokers].
    Ben Saad H; Ben Amor L; Ben Mdalla S; Ghannouchi I; Ben Essghair M; Sfaxi R; Garrouche A; Rouatbi N; Rouatbi S
    Rev Mal Respir; 2014 Jan; 31(1):29-40. PubMed ID: 24461440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic obstructive pulmonary disease in patients with end-stage kidney disease on hemodialysis.
    Plesner LL; Warming PE; Nielsen TL; Dalsgaard M; Schou M; Høst U; Rydahl C; Brandi L; Køber L; Vestbo J; Iversen K
    Hemodial Int; 2016 Jan; 20(1):68-77. PubMed ID: 26245152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FEV1/FEV6 is effective as a surrogate for FEV1/FVC in the diagnosis of chronic obstructive pulmonary disease.
    Venkatachalam P; Dwivedi DP; Govindraj V
    Indian J Tuberc; 2021 Apr; 68(2):230-235. PubMed ID: 33845957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the Emphysema Index Combined with the Chronic Obstructive Pulmonary Disease Assessment Test Score in the Evaluation of Chronic Obstructive Pulmonary Disease.
    Ding Q; Wei X; Li J; Gao YZ; Xu SD; Yu N; Mi JY; Mi BB; Guo YM
    Can Respir J; 2021; 2021():9996305. PubMed ID: 34691315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of a Post-Bronchodilator FEV
    Moffett AT; Halpern SD; Weissman GE
    medRxiv; 2024 Aug; ():. PubMed ID: 39148856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.